Publications
Specialty
Search
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/18/2024
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
Psych Congress Network
09/18/2024
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Vascular Disease Management, CardioVascular
09/18/2024
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Pharmacy Learning Network
09/18/2024
True or False: Amyloid plaque levels begin to rise again within 1 year of donanemab treatment.
ePlasty, Surgery
09/18/2024
This study surveyed Argentinian plastic surgeons to assess variability in breast augmentation practices and compared results with scientific evidence.
EP Lab Digest
09/18/2024
Asset acquisition of Cook Medical’s end-to-end lead management product portfolio strengthens Merit’s existing electrophysiology and CRM business
Journal of Clinical Pathways
09/18/2024
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Vascular Disease Management, CardioVascular, Cath Lab Digest
09/18/2024
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/18/2024
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
ePlasty, Surgery
09/18/2024
This study examines the use of polydioxanone (PDO) mesh in 522 breast implant surgeries to enhance aesthetic outcomes.
Rheumatology & Arthritis
09/18/2024
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, EP Lab Digest
09/18/2024
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
09/18/2024
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
First Report Managed Care, Population Health
09/18/2024
The aftermath of legal challenges and state legislation continues to reshape the landscape of copay accumulator programs, forcing payers and manufacturers to adapt their strategies.
Oncology
09/18/2024
Based on results from the KEYNOTE-483 study, the US FDA has approved pembrolizumab plus pemetrexed and platinum-based chemotherapy as first-line treatment for patients with unresectable advanced or metastatic malignant pleural mesothelioma.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/18/2024
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Vascular Disease Management, CardioVascular, Cath Lab Digest
09/18/2024
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
Rheumatology & Arthritis
09/18/2024
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and reg
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
09/17/2024
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Wounds
09/17/2024
Objective: To retrospectively assess the effect of polylactic acid in promoting chronic wound healing compared with 2 other well-established cellular, acellular, and matrix-like products.